Reviewing meds with a pharmacist may boost adherence

Engaging Medicare members associated with improved adherence: Part of the Star rating composite score

How well do medication management therapy (MTM) programs work? This study showed that members who completed comprehensive medication reviews (CMRs), as part of a MTM program, improved the percentage of adherent members. 40% more members were adherent. (Adherence was defined as having a proportion of days covered over 80%.) Adherence was measured for medications to treat diabetes, high blood pressure and high cholesterol.

Medication Therapy Management (MTM) Comprehensive Medication Review (CMR) Impact Assessment (Fall 2015)

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

Related news

Perspectives

April 15, 2024

Oncology Insights: Cancer treatment is personal

Precision medicine, or personalized medicine, uses genes or proteins to diagnose or treat disease. This medical care design has significantly impacted oncology and grew out of a need to improve and individualize patient treatments

Perspectives

April 15, 2024

High-Cost Therapy Profile

Detailed information about prademagene zamikeracel Topical surgical application

Perspectives

April 15, 2024

May 2024 decisions expected from the FDA

Your monthly synopsis of new drugs expected to hit the market

View all news